AD-AID patients carrying heterozygous AICDA variants affecting the last 9–13 residues of the C-terminal NES domain have been reported to uniformly present with impaired Ig CSR; in contrast the effect on SHM of Ig H chain genes is variable [12, 16, 30]. The gene discussed is AICDA; the disease is Alzheimer disease.